Reduced nocturnal hypoglycaemia with basal insulin peglispro compared with insulin glargine: pooled analyses of five randomized controlled trials

Basal insulin peglispro (BIL) is a novel basal insulin with hepato‐preferential action, resulting from reduced peripheral effects. This report summarizes hypoglycaemia data from five BIL phase III studies with insulin glargine as the comparator, including three double‐blind trials. Prespecified pool...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosenstock, Julio, Marre, Michel, Qu, Yongming, Zhang, Shuyu, Bastyr, Edward J., Prince, Melvin J., Chang, Annette M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2016
Materias:
Themed Section‐bil
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5096011/
https://www.ncbi.nlm.nih.gov/pubmed/27484021
http://dx.doi.org/10.1111/dom.12757

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5096011/
https://www.ncbi.nlm.nih.gov/pubmed/27484021
http://dx.doi.org/10.1111/dom.12757

Ejemplares similares